Quipt Home Medical Corp. (QIPT)
USD 2.02
(-8.18%)
USD 2.02
(-8.18%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 247.4 Million USD | 87.13% |
| 2022 | 132.21 Million USD | 21.77% |
| 2021 | 108.57 Million USD | 51.17% |
| 2020 | 71.81 Million CAD | 72.35% |
| 2019 | 41.67 Million CAD | 9.64% |
| 2018 | 38 Million CAD | -62.94% |
| 2017 | 102.55 Million CAD | -8.06% |
| 2016 | 111.53 Million CAD | -29.84% |
| 2015 | 158.97 Million CAD | 337.55% |
| 2014 | 36.33 Million CAD | 325.11% |
| 2013 | 8.54 Million CAD | 230.75% |
| 2012 | 2.58 Million CAD | 10.01% |
| 2011 | 2.34 Million CAD | -23.29% |
| 2010 | 3.06 Million CAD | 1046.17% |
| 2009 | 267.17 Thousand CAD | -76.03% |
| 2008 | 1.11 Million CAD | -43.87% |
| 2007 | 1.98 Million CAD | 32.63% |
| 2006 | 1.49 Million CAD | -1.79% |
| 2005 | 1.52 Million CAD | -37.09% |
| 2004 | 2.42 Million CAD | 30.46% |
| 2003 | 1.85 Million CAD | 18.69% |
| 2002 | 1.56 Million CAD | 71.88% |
| 2001 | 910.5 Thousand CAD | 6.41% |
| 2000 | 855.66 Thousand CAD | 408.35% |
| 1999 | 168.32 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 242.64 Million USD | -1.42% |
| 2024 Q2 | 248.35 Million USD | 1.94% |
| 2024 Q3 | 249.74 Million USD | 0.47% |
| 2023 Q2 | 225.54 Million USD | 71.22% |
| 2023 Q1 | 131.72 Million USD | -0.37% |
| 2023 Q3 | 242.38 Million USD | 7.47% |
| 2023 Q4 | 247.4 Million USD | 2.07% |
| 2023 FY | 247.4 Million USD | 87.13% |
| 2022 FY | 132.21 Million USD | 21.77% |
| 2022 Q1 | 107.37 Million USD | -1.1% |
| 2022 Q4 | 132.21 Million USD | 1.33% |
| 2022 Q2 | 110.52 Million USD | 2.93% |
| 2022 Q3 | 130.47 Million USD | 18.05% |
| 2021 Q1 | 78.56 Million USD | 9.39% |
| 2021 FY | 108.57 Million USD | 51.17% |
| 2021 Q4 | 108.57 Million USD | 1.91% |
| 2021 Q3 | 106.54 Million USD | 18.74% |
| 2021 Q2 | 89.72 Million USD | 14.21% |
| 2020 Q4 | 71.81 Million CAD | 0.95% |
| 2020 FY | 71.81 Million CAD | 72.35% |
| 2020 Q3 | 71.14 Million CAD | 55.92% |
| 2020 Q1 | 46.37 Million CAD | 11.3% |
| 2020 Q2 | 45.62 Million CAD | -1.62% |
| 2019 Q2 | 52.46 Million CAD | 27.72% |
| 2019 Q3 | 39.29 Million CAD | -25.11% |
| 2019 Q4 | 41.67 Million CAD | 6.06% |
| 2019 FY | 41.67 Million CAD | 9.64% |
| 2019 Q1 | 41.07 Million CAD | 8.08% |
| 2018 Q3 | 36.08 Million CAD | -0.45% |
| 2018 Q1 | 38.64 Million CAD | -62.32% |
| 2018 FY | 38 Million CAD | -62.94% |
| 2018 Q2 | 36.24 Million CAD | -6.21% |
| 2018 Q4 | 38 Million CAD | 5.34% |
| 2017 Q1 | 110.54 Million CAD | -0.88% |
| 2017 Q4 | 102.55 Million CAD | -10.24% |
| 2017 Q3 | 114.25 Million CAD | 0.9% |
| 2017 Q2 | 113.23 Million CAD | 2.43% |
| 2017 FY | 102.55 Million CAD | -8.06% |
| 2016 Q1 | 171.47 Million CAD | 7.86% |
| 2016 Q3 | 161.39 Million CAD | -6.86% |
| 2016 Q4 | 111.53 Million CAD | -30.89% |
| 2016 FY | 111.53 Million CAD | -29.84% |
| 2016 Q2 | 173.28 Million CAD | 1.05% |
| 2015 Q3 | 220.79 Million CAD | 254.96% |
| 2015 Q4 | 158.97 Million CAD | -28.0% |
| 2015 Q2 | 62.2 Million CAD | 34.41% |
| 2015 FY | 158.97 Million CAD | 337.55% |
| 2015 Q1 | 46.28 Million CAD | 27.38% |
| 2014 Q2 | 18.96 Million CAD | 40.43% |
| 2014 Q3 | 24.76 Million CAD | 30.57% |
| 2014 Q4 | 36.33 Million CAD | 46.71% |
| 2014 Q1 | 13.5 Million CAD | 58.02% |
| 2014 FY | 36.33 Million CAD | 325.11% |
| 2013 FY | 8.54 Million CAD | 230.75% |
| 2013 Q1 | 2.71 Million CAD | 4.91% |
| 2013 Q4 | 8.54 Million CAD | 141.56% |
| 2013 Q3 | 3.53 Million CAD | 33.68% |
| 2013 Q2 | 2.64 Million CAD | -2.37% |
| 2012 Q4 | 2.58 Million CAD | -14.85% |
| 2012 FY | 2.58 Million CAD | 10.01% |
| 2012 Q2 | 3.49 Million CAD | -8.47% |
| 2012 Q1 | 3.81 Million CAD | 62.41% |
| 2012 Q3 | 3.03 Million CAD | -13.09% |
| 2011 FY | 2.34 Million CAD | -23.29% |
| 2011 Q4 | 2.34 Million CAD | -4.89% |
| 2011 Q3 | 2.46 Million CAD | -4.5% |
| 2011 Q2 | 2.58 Million CAD | -10.29% |
| 2011 Q1 | 2.88 Million CAD | -5.86% |
| 2010 Q4 | 3.06 Million CAD | 0.0% |
| 2010 Q1 | 171.4 Thousand CAD | -11.08% |
| 2010 FY | 3.06 Million CAD | 1046.17% |
| 2010 Q2 | 159.19 Thousand CAD | -7.12% |
| 2009 Q2 | 206.63 Thousand CAD | -6.63% |
| 2009 Q3 | 267.17 Thousand CAD | 29.29% |
| 2009 Q1 | 221.3 Thousand CAD | -79.33% |
| 2009 Q4 | 192.75 Thousand CAD | -27.85% |
| 2009 FY | 267.17 Thousand CAD | -76.03% |
| 2008 Q4 | 1.07 Million CAD | -3.94% |
| 2008 Q1 | 1.98 Million CAD | 1.19% |
| 2008 Q3 | 1.11 Million CAD | -38.93% |
| 2008 Q2 | 1.82 Million CAD | -7.87% |
| 2008 FY | 1.11 Million CAD | -43.87% |
| 2007 Q2 | 1.63 Million CAD | 18.79% |
| 2007 Q1 | 1.38 Million CAD | -3.74% |
| 2007 Q4 | 1.95 Million CAD | -1.42% |
| 2007 FY | 1.98 Million CAD | 32.63% |
| 2007 Q3 | 1.98 Million CAD | 21.11% |
| 2006 Q1 | 1.57 Million CAD | -1.13% |
| 2006 Q4 | 1.43 Million CAD | -4.22% |
| 2006 FY | 1.49 Million CAD | -1.79% |
| 2006 Q2 | 1.54 Million CAD | -1.5% |
| 2006 Q3 | 1.49 Million CAD | -3.21% |
| 2005 FY | 1.52 Million CAD | -37.09% |
| 2005 Q1 | 1.88 Million CAD | -13.12% |
| 2005 Q2 | 1.55 Million CAD | -17.31% |
| 2005 Q4 | 1.58 Million CAD | 4.2% |
| 2005 Q3 | 1.52 Million CAD | -2.07% |
| 2004 Q4 | 2.16 Million CAD | -10.59% |
| 2004 Q1 | 2.27 Million CAD | 26.25% |
| 2004 FY | 2.42 Million CAD | 30.46% |
| 2004 Q2 | 3.44 Million CAD | 51.66% |
| 2004 Q3 | 2.42 Million CAD | -29.74% |
| 2003 Q3 | 1.85 Million CAD | 11.8% |
| 2003 Q2 | 1.66 Million CAD | 8.06% |
| 2003 FY | 1.85 Million CAD | 18.69% |
| 2003 Q1 | 1.53 Million CAD | 15.54% |
| 2003 Q4 | 1.8 Million CAD | -3.02% |
| 2002 Q1 | 1.22 Million CAD | 3.66% |
| 2002 FY | 1.56 Million CAD | 71.88% |
| 2002 Q4 | 1.33 Million CAD | -14.96% |
| 2002 Q3 | 1.56 Million CAD | 26.66% |
| 2002 Q2 | 1.23 Million CAD | 0.57% |
| 2001 FY | 910.5 Thousand CAD | 6.41% |
| 2001 Q4 | 1.18 Million CAD | 0.0% |
| 2000 FY | 855.66 Thousand CAD | 408.35% |
| 1999 FY | 168.32 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -688.778% |
| BrainsWay Ltd. | 62.97 Million USD | -292.886% |
| Cerus Corporation | 197.74 Million USD | -25.113% |
| Envoy Medical, Inc. | 7.64 Million USD | -3138.325% |
| electroCore, Inc. | 16.38 Million USD | -1409.782% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -3116.433% |
| IceCure Medical Ltd | 16.41 Million USD | -1407.666% |
| Inogen, Inc. | 326.19 Million USD | 24.153% |
| OrthoPediatrics Corp. | 449.58 Million USD | 44.97% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -807.253% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -1392.297% |
| MaxCyte, Inc. | 268.27 Million USD | 7.778% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -2955.433% |
| Nexalin Technology, Inc. | 3.63 Million USD | -6712.052% |
| Orthofix Medical Inc. | 925.31 Million USD | 73.262% |
| PAVmed Inc | 33.11 Million USD | -647.027% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -72.467% |
| RxSight, Inc. | 182.55 Million USD | -35.529% |
| Sight Sciences, Inc. | 166.65 Million USD | -48.459% |
| SI-BONE, Inc. | 230.42 Million USD | -7.37% |
| TELA Bio, Inc. | 78.04 Million USD | -216.995% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 1.786% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -2205.76% |
| Acutus Medical, Inc. | 53.96 Million USD | -358.503% |
| Talis Biomedical Corporation | 98.34 Million USD | -151.584% |
| Spectral AI, Inc. | 10.69 Million USD | -2213.954% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -13.154% |
| CVRx, Inc. | 115.22 Million USD | -114.71% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -321.759% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -7841.827% |
| Bioventus Inc. | 810.91 Million USD | 69.49% |
| Venus Concept Inc. | 93.65 Million USD | -164.172% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -861.741% |
| LivaNova PLC | 2.42 Billion USD | 89.817% |
| 908 Devices Inc. | 202.98 Million USD | -21.887% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 69.274% |
| Nemaura Medical Inc. | 14.56 Million USD | -1598.854% |
| NeuroPace, Inc. | 107.65 Million USD | -129.824% |
| LENSAR, Inc. | 69.58 Million USD | -255.548% |
| Apyx Medical Corporation | 79.24 Million USD | -212.226% |
| Cutera, Inc. | 346.29 Million USD | 28.555% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -488.842% |
| BioSig Technologies, Inc. | 1.79 Million USD | -13660.178% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 8.581% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -479.94% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 93.458% |
| Axonics, Inc. | 719.92 Million USD | 65.634% |
| Outset Medical, Inc. | 313.8 Million USD | 21.158% |
| IRIDEX Corporation | 34.43 Million USD | -618.457% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 38.869% |
| IRadimed Corporation | 92.15 Million USD | -168.466% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -4608.946% |
| INVO Bioscience, Inc. | 20.88 Million USD | -1084.462% |
| Telesis Bio, Inc. | 70.41 Million USD | -251.377% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -60.548% |
| Varex Imaging Corporation | 1.24 Billion USD | 80.201% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -2557.444% |
| Pulmonx Corporation | 178.95 Million USD | -38.255% |
| Dynatronics Corporation | 25.94 Million USD | -853.75% |
| Modular Medical, Inc. | 13.8 Million USD | -1691.903% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -2206.404% |
| Semler Scientific, Inc. | 78.06 Million USD | -216.926% |
| InMode Ltd. | 863.28 Million USD | 71.341% |
| Bruker Corporation | 4.24 Billion USD | 94.178% |
| Cytosorbents Corporation | 53.26 Million USD | -364.523% |
| DexCom, Inc. | 6.26 Billion USD | 96.051% |
| Align Technology, Inc. | 6.08 Billion USD | 95.933% |
| Viveve Medical, Inc. | 25.91 Million USD | -854.764% |
| ZimVie Inc. | 1.2 Billion USD | 79.474% |
| Movano Inc. | 9.42 Million USD | -2526.133% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 50.287% |
| Nexalin Technology, Inc. | 3.63 Million USD | -6712.052% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -321.759% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 74.03% |
| Profound Medical Corp. | 43.68 Million USD | -466.328% |
| Insulet Corporation | 2.58 Billion USD | 90.441% |
| enVVeno Medical Corporation | 48.63 Million USD | -408.704% |
| Surmodics, Inc. | 185.73 Million USD | -33.206% |
| iCAD, Inc. | 41.41 Million USD | -497.344% |
| Nuwellis, Inc. | 9.77 Million USD | -2432.323% |
| Biotricity, Inc. | 5.94 Million USD | -4063.278% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 42.881% |
| Aethlon Medical, Inc. | 8.24 Million USD | -2900.346% |
| InspireMD, Inc. | 47.64 Million USD | -419.296% |
| PAVmed Inc. | 33.11 Million USD | -647.027% |
| BIOLASE, Inc. | 35.1 Million USD | -604.846% |
| Beyond Air, Inc. | 56.96 Million USD | -334.346% |
| FONAR Corporation | 214.24 Million USD | -15.478% |
| AxoGen, Inc. | 196.82 Million USD | -25.698% |
| Vivani Medical, Inc. | 45.79 Million USD | -440.228% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 12.091% |
| Inari Medical, Inc. | 674.23 Million USD | 63.305% |
| UFP Technologies, Inc. | 404.13 Million USD | 38.781% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -957.364% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -2503.442% |
| Tenon Medical, Inc. | 6.34 Million USD | -3799.259% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -2530.041% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -138.701% |
| AdaptHealth Corp. | 4.61 Billion USD | 94.645% |
| Sintx Technologies, Inc. | 15.36 Million USD | -1510.205% |
| NanoVibronix, Inc. | 6.67 Million USD | -3607.042% |
| Quanterix Corporation | 425.01 Million USD | 41.788% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -2557.444% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -360.491% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 85.83% |
| TransMedics Group, Inc. | 706.04 Million USD | 64.959% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -291.518% |
| NeuroMetrix, Inc. | 21.42 Million USD | -1054.793% |
| Hyperfine, Inc. | 94.19 Million USD | -162.644% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 7.904% |
| Biomerica, Inc. | 9.25 Million USD | -2573.525% |
| Bone Biologics Corporation | 3.73 Million USD | -6519.146% |
| AVITA Medical, Inc. | 144.33 Million USD | -71.406% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -4981.779% |
| Silk Road Medical, Inc | 265.3 Million USD | 6.747% |